- Home
- PB vs BIO Comparison
PB vs BIO Comparison
Compare PB & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PB | BIO |
|---|---|---|
| Founded | 1983 | 1952 |
| Country | US | |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 7.2B |
| IPO Year | 1998 | N/A |
Fundamental Metrics
Financial Performance| Metric | PB | BIO |
|---|---|---|
| Price | $72.76 | $270.16 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 4 |
| Target Price | $79.38 | ★ $358.50 |
| AVG Volume (30 Days) | ★ 1.6M | 291.3K |
| Earning Date | 04-29-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.28% | N/A |
| EPS Growth | ★ 11.97 | N/A |
| EPS | ★ 4.23 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $41.06 | $1.50 |
| Revenue Next Year | $17.19 | $2.23 |
| P/E Ratio | $17.32 | ★ $9.72 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $61.07 | $211.43 |
| 52 Week High | $78.05 | $343.12 |
Technical Indicators
Market Signals| Indicator | PB | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 51.07 | 35.29 |
| Support Level | $72.22 | $251.00 |
| Resistance Level | $74.36 | $301.47 |
| Average True Range (ATR) | 1.91 | 10.62 |
| MACD | -0.05 | -3.26 |
| Stochastic Oscillator | 52.65 | 31.10 |
Price Performance
Historical ComparisonAbout PB Prosperity Bancshares Inc.
Prosperity Bancshares Inc provides retail and commercial banking services to individuals and small to midsize businesses. It provides a wide array of financial products and services to businesses and consumers throughout Texas and Oklahoma. The group provides Personal, Business, Mortgage, and Banking Services.
About BIO Bio-Rad Laboratories Inc.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.